Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Annovis Bio, Inc. | tm2013055d1_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - Annovis Bio, Inc. | tm2013055d1_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Annovis Bio, Inc. | tm2013055d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Annovis Bio, Inc. | tm2013055d1_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Annovis Bio, Inc. | tm2013055d1_ex23-1.htm |
| EX-10.9 - EXHIBIT 10.9 - Annovis Bio, Inc. | tm2013055d1_ex10-9.htm |
| EX-10.1 - EXHIBIT 10.1 - Annovis Bio, Inc. | tm2013055d1_ex10-1.htm |
| EX-4.3 - EXHIBIT 4.3 - Annovis Bio, Inc. | tm2013055d1_ex4-3.htm |
| EX-4.2 - EXHIBIT 4.2 - Annovis Bio, Inc. | tm2013055d1_ex4-2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Annovis Bio, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Maria Maccecchini, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: March 25, 2020 | /s/ Maria Maccecchini | |
| Maria Maccecchini | ||
President and Chief Executive Officer |